Á¶¼±´ëÇб³º´¿ø Á¦134Â÷ ´ëÇѽÉÀåÇÐȸ È£³²Áöȸ Çмú´ëȸ ¹× ¿¬¼ö°Á : 2022-12-02±³À°ÀÏÀÚ : 2022-12-02
±³À°Àå¼Ò : Á¶¼±´ëÇб³º´¿ø ±èµ¿±¹È¦ (ÀǼº°ü 5Ãþ)
±³À°ÁÖÁ¦ :
Á¦134Â÷ ´ëÇѽÉÀåÇÐȸ È£³²Áöȸ Çмú´ëȸ ¹× ¿¬¼ö°ÁÂÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : È£³²Áöȸ
´ã´çÀÚ : °íÇý¼÷
¿¬¶ôó : 063-859-2520
À̸ÞÀÏ :
cardio2520@wkuh.org ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 150¸í
Èñ¸ÁÆòÁ¡ : 2Á¡
Áö¿ª :
±¤ÁÖ±¤¿ª½Ã±³À°½Ã°£ : 2 ½Ã°£ 45ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 12-02 Á¶¼±´ëÇб³º´¿ø ÀǼº°ü 15:00~15:10 De-escalation antiplatelet therapy after PCI in Korean patients with ACS ±èÇö±¹(Á¶¼±ÀÇ´ë)
±³À°½Ã°£ 12-02 Á¶¼±´ëÇб³º´¿ø ÀǼº°ü 15:10~15:20 Optimal lipid lowering therapy in Koreans with atherosclerotic cardiovascular disease ±èÀ̽Ä(ÀüºÏÀÇ´ë)
±³À°½Ã°£ 12-02 Á¶¼±´ëÇб³º´¿ø ÀǼº°ü 15:20~15:30 Revascularization strategy for ischemic cardiomyopathy ¾ÈÁØÈ£(Àü³²ÀÇ´ë)
Åä·Ð 12-02 Á¶¼±´ëÇб³º´¿ø ÀǼº°ü 15:30~15:45 ÅäÀÇ ´Ù°»ç(´Ù¼Ò¼Ó)
ÈÞ½Ä 12-02 Á¶¼±´ëÇб³º´¿ø ÀǼº°ü 15:45~16:00 ÈÞ½Ä ()
±³À°½Ã°£ 12-02 Á¶¼±´ëÇб³º´¿ø ÀǼº°ü 16:00~16:10 Pros and cons of leadless pacemaker ±èÀ¯¸®(Àü³²ÀÇ´ë)
±³À°½Ã°£ 12-02 Á¶¼±´ëÇб³º´¿ø ÀǼº°ü 16:10~16:20 Physiological pacing: wher are we now? ±è¼º¼ö(Á¶¼±ÀÇ´ë)
±³À°½Ã°£ 12-02 Á¶¼±´ëÇб³º´¿ø ÀǼº°ü 16:20~16:30 Subclinical atrial fibrillation: clinical implications, detection and management Á¤Çü±â(¿ø±¤ÀÇ´ë)
Åä·Ð 12-02 Á¶¼±´ëÇб³º´¿ø ÀǼº°ü 16:30~16:45 ÅäÀÇ ´Ù°»ç(´Ù¼Ò¼Ó)
±³À°½Ã°£ 12-02 Á¶¼±´ëÇб³º´¿ø ÀǼº°ü 16:45~16:55 How to approach heart failure in cancer pateints receiving cardiotoxic therapies ÀÌ´©¸®(Àü³²ÀÇ´ë)
±³À°½Ã°£ 12-02 Á¶¼±´ëÇб³º´¿ø ÀǼº°ü 16:55~17:05 Management of HFpEF and HFmrEF ÀÌÀÚ¿¬(ÀüºÏÀÇ´ë)
±³À°½Ã°£ 12-02 Á¶¼±´ëÇб³º´¿ø ÀǼº°ü 17:05~17:15 Nuclear imaging in heart failure Á¶»ó°Ç(Àü³²ÀÇ´ë)
Åä·Ð 12-02 Á¶¼±´ëÇб³º´¿ø ÀǼº°ü 17:15~17:30 ÅäÀÇ ´Ù°»ç(´Ù¼Ò¼Ó)
±³À°½Ã°£ 12-02 Á¶¼±´ëÇб³º´¿ø ÀǼº°ü 17:30~18:00 ºÎÁ¤¸Æ°ú ÇÔ²² ÇÑ ¿©Á¤ Á¶Á¤°ü(Àü³²ÀÇ´ë)